In a large, head-to-head trial pitting collagenase injections against limited fasciotomy as treatments for Dupuytren's contracture, the knife won. In the open-label trial, self-reported hand health ...
Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Dupuytren's Disease Market - A Global and Regional Analysis: Focus on Drug Type and Region - Analysis and Forecast, 2025-2035" has been added to ...
The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
About Dupuytren's ContractureDC is a lifelong condition that may get worse over time. It's caused by a buildup of collagen in the hand, which forms a rope-like cord that pulls fingers toward the palm ...
Treatment options for Dupuytren’s contracture include limited fasciectomy and collagenase injection, but data comparing the two approaches are lacking. New research findings are summarized in a short ...
Suggest on MSN
Pulitzer Prize Winner Undergoes Hand Surgery
Talk about a rewrite. A Pulitzer Prize-winning author is on the mend after some serious hand surgery, sharing an X-ray of her “badass” rebuilt digit. Barbara Kingsolver, who won the coveted award for ...
(MENAFN- GlobeNewsWire - Nasdaq) Despite challenges like disease recurrence and high treatment costs, investments in research and non-surgical therapies present growth opportunities. North America ...
DUBLIN, Jan. 19, 2024 /PRNewswire/ -- Endo International plc (OTC: ENDPQ) announced today that two new presentations related to Dupuytren's contracture and XIAFLEX ® (collagenase clostridium ...
In a randomized trial in patients with moderate Dupuytren’s contracture, collagenase was not noninferior to limited fasciectomy with respect to the Patient Evaluation Measure score at 1 year after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback